Trial Profile
An Open-label, Randomized, Single Sequence, Two Period Study to Assess the Effect of Repeat Oral Dosing of Ketoconazole on the Pharmacokinetics of a Single Oral Dose of GSK962040 in Healthy Volunteers.
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 20 Sep 2023
Price :
$35
*
At a glance
- Drugs Camicinal (Primary) ; Ketoconazole
- Indications Diabetic gastroparesis
- Focus Pharmacokinetics
- Sponsors GlaxoSmithKline; GSK
- 08 Jan 2010 New trial record